And Millennium Pharmaceuticals closed at $115.14, up $3.20.

Millennium Pharmaceuticals of Cambridge, Mass., is using genomics to understand disease processes to develop drugs.

Millennium Pharmaceuticals dropped 28 7/8, to 171 3/4.

Millennium Pharmaceuticals, for instance, uses biological knowledge and other techniques to first estimate what genes are likely to be involved in a disease.

Millennium Pharmaceuticals, a leader in genomics, has no drugs in clinical trials resulting from its own gene hunting.

And Millennium Pharmaceuticals slumped 32 3/4, to 141 15/16.

Its nearest competitor, Millennium Pharmaceuticals, has started clinical trials on one drug that it discovered using genomics.

Millennium Pharmaceuticals said yesterday that the first drug discovered using its genomics technology had entered clinical trials.

In 1998 the company was merged with Millennium Pharmaceuticals, and Cuticchia returned to academics.

And Millennium Pharmaceuticals closed at $70.50, up $4.31.